Celadon Pharmaceuticals Plc (AIM: CEL)

Celadon Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Aug 31, 2020
Cash & Equivalents	1.26	1.26	5.06	3.82	0.3	5.49
Cash & Short-Term Investments	1.26	1.26	5.06	3.82	0.3	5.49
Cash Growth	-75.12%	-75.12%	32.38%	1176.55%	-94.54%	369212.99%
Accounts Receivable	0.08	0.08	-	0.06	-	-
Other Receivables	0.77	0.77	1.06	0.04	0.15	0
Receivables	0.84	0.84	1.06	0.1	0.15	0
Inventory	0.1	0.1	0.02	0	-	-
Prepaid Expenses	0.3	0.3	0.19	0.16	0.04	0.01
Other Current Assets	-	-	-	-	0.25	-
Total Current Assets	2.5	2.5	6.33	4.09	0.74	5.5
Property, Plant & Equipment	6.18	6.18	6.28	3.31	3.03	-
Long-Term Investments	0.22	0.22	0.22	0.2	-	-
Goodwill	0.08	0.08	0.08	0.72	0.08	-
Other Intangible Assets	0.25	0.25	0.35	0.45	-	-
Total Assets	9.22	9.22	13.25	8.76	3.85	5.5
Accounts Payable	0.33	0.33	0.54	0.16	0.26	0
Accrued Expenses	0.45	0.45	0.48	0.52	0.1	0.03
Short-Term Debt	-	-	-	4.93	-	-
Current Portion of Long-Term Debt	0.02	0.02	0.01	2.17	0.01	-
Current Portion of Leases	0.05	0.05	0.06	0.34	-	-
Current Income Taxes Payable	0.08	0.08	0.09	0.07	-	0
Other Current Liabilities	-	-	-	0.38	0.47	0.01
Total Current Liabilities	0.96	0.96	1.2	8.58	0.83	0.04
Long-Term Debt	0.01	0.01	0.02	1.57	0.04	-
Long-Term Leases	4.63	4.63	4.54	2.92	2.87	-
Long-Term Deferred Tax Liabilities	0.04	0.04	0.06	0.09	-	-
Other Long-Term Liabilities	0.41	0.41	0.39	-	0	-
Total Liabilities	6.04	6.04	6.21	13.16	3.75	0.04
Common Stock	0.64	0.64	0.62	0.08	0	0.06
Additional Paid-In Capital	25.5	25.5	22.55	7.37	1.27	5.71
Retained Earnings	-30.73	-30.73	-22.81	-5.8	-1.17	-0.37
Comprensive Income & Other	7.74	7.74	7.31	-5.79	-	0.05
Total Common Equity	3.16	3.16	7.68	-4.14	0.1	5.46
Minority Interest	0.02	0.02	-0.64	-0.26	-	-
Shareholders' Equity	3.18	3.18	7.04	-4.4	0.1	5.46
Total Liabilities & Equity	9.22	9.22	13.25	8.76	3.85	5.5
Total Debt	4.72	4.72	4.63	11.92	2.92	-
Net Cash (Debt)	-3.46	-3.46	0.43	-8.1	-2.62	5.49
Net Cash Per Share	-0.06	-0.06	0.01	-0.18	-85.27	0.90
Filing Date Shares Outstanding	64.21	64.21	61.67	8.03	0.03	6.13
Total Common Shares Outstanding	64.21	64.21	61.67	8.03	0.03	6.13
Working Capital	1.55	1.55	5.13	-4.5	-0.1	5.46
Book Value Per Share	0.05	0.05	0.12	-0.52	3.22	0.89
Tangible Book Value	2.83	2.83	7.25	-5.31	0.02	5.46
Tangible Book Value Per Share	0.04	0.04	0.12	-0.66	0.61	0.89
Machinery	1.35	1.35	1.1	0.79	0.51	-
Construction In Progress	2.01	2.01	1.99	-	-	-
Leasehold Improvements	0.3	0.3	0.25	0.47	0.2	-

Source: S&P Capital IQ. Standard template. Financial Sources.